questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Globulines
Sérum-globulines
Immunoglobulines
Anticorps
Isotypes des immunoglobulines
Immunoglobuline A
Immunoglobuline A sécrétoire
Immunoglobuline A sécrétoire : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Immunoglobuline A sécrétoire : Questions médicales les plus fréquentes",
"headline": "Immunoglobuline A sécrétoire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Immunoglobuline A sécrétoire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-12",
"dateModified": "2025-04-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Immunoglobuline A sécrétoire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Immunoglobuline A",
"url": "https://questionsmedicales.fr/mesh/D007070",
"about": {
"@type": "MedicalCondition",
"name": "Immunoglobuline A",
"code": {
"@type": "MedicalCode",
"code": "D007070",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.619.026"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Immunoglobuline A sécrétoire",
"alternateName": "Immunoglobulin A, Secretory",
"code": {
"@type": "MedicalCode",
"code": "D007071",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sonya Kumar Bharathkar",
"url": "https://questionsmedicales.fr/author/Sonya%20Kumar%20Bharathkar",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, University of Illinois Urbana-Champaign, Urbana, United States."
}
},
{
"@type": "Person",
"name": "Beth M Stadtmueller",
"url": "https://questionsmedicales.fr/author/Beth%20M%20Stadtmueller",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, University of Illinois Urbana-Champaign, Urbana, United States."
}
},
{
"@type": "Person",
"name": "Georgy A Nevinsky",
"url": "https://questionsmedicales.fr/author/Georgy%20A%20Nevinsky",
"affiliation": {
"@type": "Organization",
"name": "Institute of Chemical Biology and Fundamental Medicine, SD of Russian Academy of Sciences, 8 Lavrentiev Ave., Novosibirsk 630090, Russia. Electronic address: nevinsky@niboch.nsc.ru."
}
},
{
"@type": "Person",
"name": "Nikit Kumar",
"url": "https://questionsmedicales.fr/author/Nikit%20Kumar",
"affiliation": {
"@type": "Organization",
"name": "Department of Structural Biology, Genentech, Inc., South San Francisco, CA, USA 94080."
}
},
{
"@type": "Person",
"name": "Christopher P Arthur",
"url": "https://questionsmedicales.fr/author/Christopher%20P%20Arthur",
"affiliation": {
"@type": "Organization",
"name": "Department of Structural Biology, Genentech, Inc., South San Francisco, CA, USA 94080."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "An up-to-date myopathologic characterisation of facioscapulohumeral muscular dystrophy type 1 muscle biopsies shows sarcolemmal complement membrane attack complex deposits and increased skeletal muscle regeneration.",
"datePublished": "2024-01-14",
"url": "https://questionsmedicales.fr/article/38306719",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.nmd.2024.01.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "Multiparametric MRI and T2/FLAIR mismatch complements the World Health Organization 2021 classification for the diagnosis of IDH-mutant 1p/19q non-co-deleted/ATRX-mutant astrocytoma.",
"datePublished": "2023-12-05",
"url": "https://questionsmedicales.fr/article/38101998",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.crad.2023.11.016"
}
},
{
"@type": "ScholarlyArticle",
"name": "Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established highrisk factors.",
"datePublished": "2023-04-01",
"url": "https://questionsmedicales.fr/article/36519324",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3324/haematol.2022.281420"
}
},
{
"@type": "ScholarlyArticle",
"name": "Single Nucleotide Polymorphism-Based Real-Time PCR Screening Assay for Rapid Tracking of Bacterial Infection Clusters To Complement Whole-Genome Sequencing Efforts during Outbreak Investigations.",
"datePublished": "2022-10-17",
"url": "https://questionsmedicales.fr/article/36250868",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/spectrum.03036-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Can 10× cheaper, lower-efficiency particulate air filters and box fans complement High-Efficiency Particulate Air (HEPA) purifiers to help control the COVID-19 pandemic?",
"datePublished": "2022-05-14",
"url": "https://questionsmedicales.fr/article/35580674",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.scitotenv.2022.155884"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Globulines",
"item": "https://questionsmedicales.fr/mesh/D005916"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sérum-globulines",
"item": "https://questionsmedicales.fr/mesh/D012712"
},
{
"@type": "ListItem",
"position": 6,
"name": "Immunoglobulines",
"item": "https://questionsmedicales.fr/mesh/D007136"
},
{
"@type": "ListItem",
"position": 7,
"name": "Anticorps",
"item": "https://questionsmedicales.fr/mesh/D000906"
},
{
"@type": "ListItem",
"position": 8,
"name": "Isotypes des immunoglobulines",
"item": "https://questionsmedicales.fr/mesh/D007132"
},
{
"@type": "ListItem",
"position": 9,
"name": "Immunoglobuline A",
"item": "https://questionsmedicales.fr/mesh/D007070"
},
{
"@type": "ListItem",
"position": 10,
"name": "Immunoglobuline A sécrétoire",
"item": "https://questionsmedicales.fr/mesh/D007071"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Immunoglobuline A sécrétoire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Immunoglobuline A sécrétoire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Immunoglobuline A sécrétoire",
"description": "Comment mesurer l'IgA sécrétoire ?\nQuels tests diagnostiques sont utilisés ?\nL'IgA sécrétoire est-elle liée à des maladies ?\nQuels symptômes peuvent indiquer un déficit d'IgA ?\nComment évaluer la fonction immunitaire ?",
"url": "https://questionsmedicales.fr/mesh/D007071?mesh_terms=Complement+C5&page=172#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Immunoglobuline A sécrétoire",
"description": "Quels symptômes sont associés à un déficit d'IgA ?\nL'IgA sécrétoire affecte-t-elle la digestion ?\nPeut-on avoir des symptômes respiratoires ?\nLes allergies sont-elles liées à l'IgA ?\nComment l'IgA sécrétoire influence-t-elle l'immunité ?",
"url": "https://questionsmedicales.fr/mesh/D007071?mesh_terms=Complement+C5&page=172#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Immunoglobuline A sécrétoire",
"description": "Comment prévenir les infections respiratoires ?\nL'alimentation influence-t-elle l'IgA ?\nLe stress affecte-t-il l'IgA ?\nLes probiotiques aident-ils l'IgA ?\nLes habitudes de vie influencent-elles l'IgA ?",
"url": "https://questionsmedicales.fr/mesh/D007071?mesh_terms=Complement+C5&page=172#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Immunoglobuline A sécrétoire",
"description": "Comment traiter un déficit d'IgA ?\nDes suppléments d'IgA existent-ils ?\nLes vaccins sont-ils efficaces ?\nComment prévenir les infections ?\nY a-t-il des traitements alternatifs ?",
"url": "https://questionsmedicales.fr/mesh/D007071?mesh_terms=Complement+C5&page=172#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Immunoglobuline A sécrétoire",
"description": "Quelles complications peuvent survenir avec un déficit d'IgA ?\nLe déficit d'IgA augmente-t-il le risque d'infections ?\nY a-t-il un lien avec les maladies auto-immunes ?\nLes allergies peuvent-elles s'aggraver ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D007071?mesh_terms=Complement+C5&page=172#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Immunoglobuline A sécrétoire",
"description": "Quels sont les facteurs de risque d'un déficit d'IgA ?\nL'âge influence-t-il l'IgA sécrétoire ?\nLe sexe joue-t-il un rôle ?\nLes infections virales affectent-elles l'IgA ?\nLe mode de vie influence-t-il l'IgA ?",
"url": "https://questionsmedicales.fr/mesh/D007071?mesh_terms=Complement+C5&page=172#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer l'IgA sécrétoire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IgA sécrétoire est mesurée par des tests d'immunoessai sur des échantillons de mucus ou de salive."
}
},
{
"@type": "Question",
"name": "Quels tests diagnostiques sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sérologiques et des analyses de fluides corporels sont utilisés pour évaluer l'IgA sécrétoire."
}
},
{
"@type": "Question",
"name": "L'IgA sécrétoire est-elle liée à des maladies ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux d'IgA sécrétoire peuvent indiquer des maladies auto-immunes ou des infections."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un déficit d'IgA ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections récurrentes des voies respiratoires et digestives peuvent signaler un déficit d'IgA."
}
},
{
"@type": "Question",
"name": "Comment évaluer la fonction immunitaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'anticorps spécifiques et des évaluations cliniques sont utilisés pour évaluer la fonction immunitaire."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à un déficit d'IgA ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des infections fréquentes, des allergies et des problèmes digestifs."
}
},
{
"@type": "Question",
"name": "L'IgA sécrétoire affecte-t-elle la digestion ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un faible niveau d'IgA sécrétoire peut entraîner des troubles digestifs et des infections intestinales."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes respiratoires ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un déficit d'IgA sécrétoire peut provoquer des infections respiratoires fréquentes."
}
},
{
"@type": "Question",
"name": "Les allergies sont-elles liées à l'IgA ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un déséquilibre d'IgA sécrétoire peut contribuer à des réactions allergiques."
}
},
{
"@type": "Question",
"name": "Comment l'IgA sécrétoire influence-t-elle l'immunité ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IgA sécrétoire joue un rôle clé dans la protection des muqueuses contre les agents pathogènes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections respiratoires ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène, éviter les foules et se faire vacciner sont essentiels."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle l'IgA ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée riche en nutriments peut soutenir la production d'IgA sécrétoire."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il l'IgA ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut diminuer les niveaux d'IgA sécrétoire et affaiblir l'immunité."
}
},
{
"@type": "Question",
"name": "Les probiotiques aident-ils l'IgA ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les probiotiques peuvent aider à maintenir un équilibre immunitaire et soutenir l'IgA."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles l'IgA ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des habitudes de vie saines, comme l'exercice régulier, peuvent améliorer la fonction immunitaire."
}
},
{
"@type": "Question",
"name": "Comment traiter un déficit d'IgA ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut des antibiotiques pour les infections et des immunoglobulines si nécessaire."
}
},
{
"@type": "Question",
"name": "Des suppléments d'IgA existent-ils ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de suppléments d'IgA sécrétoire disponibles sur le marché pour le traitement."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins peuvent être moins efficaces chez les personnes avec un déficit d'IgA sécrétoire."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hygiène, des vaccinations et un suivi médical régulier aident à prévenir les infections."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs comme les probiotiques peuvent aider à renforcer l'immunité."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec un déficit d'IgA ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections récurrentes, des allergies et des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Le déficit d'IgA augmente-t-il le risque d'infections ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec un déficit d'IgA sont plus susceptibles de développer des infections fréquentes."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien avec les maladies auto-immunes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un déficit d'IgA est associé à un risque accru de maladies auto-immunes comme la maladie cœliaque."
}
},
{
"@type": "Question",
"name": "Les allergies peuvent-elles s'aggraver ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec un déficit d'IgA peuvent développer des allergies plus sévères."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical régulier et un traitement approprié."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'un déficit d'IgA ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des infections fréquentes et des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il l'IgA sécrétoire ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux d'IgA sécrétoire peuvent varier avec l'âge, souvent diminuant chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des études montrent que les hommes peuvent être plus susceptibles d'avoir un déficit d'IgA."
}
},
{
"@type": "Question",
"name": "Les infections virales affectent-elles l'IgA ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales peuvent temporairement réduire les niveaux d'IgA sécrétoire."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il l'IgA ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain avec une bonne nutrition et de l'exercice peut soutenir l'IgA sécrétoire."
}
}
]
}
]
}
The aim of this study was to identify key routinely used myopathologic biomarkers of FSHD1. Needle muscle biopsies were taken in 34 affected muscles (m. quadriceps femoris (QF), n = 20, m. tibialis an...
To investigate whether T2-weighted imaging-fluid-attenuated inversion recovery (T2/FLAIR) mismatch, T2∗ dynamic susceptibility contrast (DSC) perfusion, and magnetic resonance spectroscopy (MRS) corre...
Imaging of 101 IDH-mutant diffuse glioma cases of histological grades 2-3 (2019-2021) were analysed retrospectively by two neuroradiologists blinded to the molecular diagnosis. T2/FLAIR mismatch sign ...
Sixteen of the 101 cases showed T2/FLAIR mismatch, all of which were histogenetically confirmed IDH-mutant 1p/19q non-co-deleted/ATRX mutant astrocytomas; 50% were grade 3 (8/16) and 50% grade 2 (8/16...
The T2/FLAIR mismatch sign detected diffuse astrocytomas with 100% specificity. When combined with high Cho/Cr and raised rCBV, this predicted histological grading with high accuracy. The future direc...
The variable outcome to standard immunochemotherapy for mantle cell lymphoma (MCL) patients is a clinical challenge. Established risk factors, including high MCL International Prognostic Index (MIPI),...
Infection clusters of multidrug-resistant bacteria increase mortality and entail expensive infection control measures. Whereas whole-genome sequencing (WGS) is the current gold standard to confirm inf...
Public health departments such as CDC and California Department of Public Health (CA-DPH) advise HEPA-purifiers to limit transmission of SARS-CoV-2 indoor spaces. CA-DPH recommends air exchanges per h...
To assess the efficacy and safety of bicarbonate infusion in children with Acute Diarrhea and Severe Dehydration (ADSD) having severe Non-Anion Gap Metabolic Acidemia (sNAGMA)....
Children (aged 1-144 mo) with ADSD and sNAGMA (pH ≤7.2 and/or serum bicarbonate ≤15 mEq/L) were enrolled in an open-label randomized design. Controls (n = 25) received WHO-recommended rehydration ther...
Time taken to resolve metabolic acidemia was significantly lesser with intervention [median (IQR); 8 h (4, 12) vs. 12 h (8, 24); p = 0.0067]. Intervention led to acidemia resolution in significantly m...
Additional calculated dose of bicarbonate infusion led to significantly early resolution of metabolic acidemia, lesser utilization of critical care facilities, and lesser adverse outcome in children w...
Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by uncontrolled terminal complement activation leading to intravascular hemolysis (IVH), thrombosis, and impairments in quality of life (QoL)...
Understanding the epidemiological dynamics of disease control, as well as the effectiveness, compliance, and success of the vaccination program requires an understanding of the local population's know...
A cross-sectional study was conducted in the South Gondar Zone, among residents above the age of 18 years. The study used objective measures and the constructs of the Health Belief Model. Binary logis...
The study was conducted on 1,111 study participants. The mean age is 30.83 ± 7.106. About 575 (51.8%) of the respondents have good knowledge about the COVID-19 vaccination and 43.4% have a positive at...
The level of acceptance of COVID-19 vaccination is much lower. Having a positive attitude score and good knowledge score, level of education, monthly income, presence of TV, the use of Facebook, and k...
The recent worldwide increase in malaria cases highlights the need for renewed efforts to eliminate malaria. The World Health Organization advocates that malaria surveillance becomes a core interventi...
This study was conducted in Malawi, a high malaria burden country, at the Malawi Blood Transfusion Service, which collects blood units at donation sites countrywide. A secondary analysis was conducted...
The malaria parasite prevalence in blood donors was 11.6% (614/5281 samples) increasing seasonally from December (8.6%) to April (18.3%). The median age was 21 years and 45.9% of donors were from urba...
This study demonstrates the powerful utility of screening blood donors for malaria parasites using the XN-31, which not only improves the safety of blood transfusion, but provides valuable complementa...
To assess the effect of adding an oral glucose tolerance test (OGTT) to fasting plasma glucose (FPG) in terms of detection of type 2 diabetes (T2D) and impaired glucose tolerance (IGT)....
Retrospective analysis of serial cross-sectional screening study....
Population-based health examinations within primary care in Västerbotten County, Sweden....
Individuals aged 40- 50 and 60 years with participation from 1985 to 2017. Those with previously diagnosed diabetes and FPG≥7 mmol/L were excluded....
Prevalence of hyperglycaemia on the OGTT (IGT and T2D defined as 2-hour postload capillary plasma glucose of 8.9-12.1 mmol/L and ≥12.2 mmol/L, respectively). Analyses were further stratified by age, s...
The prevalence of IGT ranged from 0.9% (95% CI 0.7% to 1.1%) to 29.6% (95% CI 27.4% to 31.7%), and the prevalence of T2D ranged from 0.06% (95% CI 0.02% to 0.11%) to 7.0% (95% CI 5.9% to 8.3%), depend...
The prevalence of hyperglycaemia on OGTT is highly dependent on age, sex and risk factor burden; OGTT should be applied selectively to high-risk groups to avoid unnecessary testing in the general popu...